Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive and cognitive symptoms in schizophrenia, and dual psychosis

María Teresa Guarro Carreras, Luis Jiménez Suárez, Laura Lago García, Laura Montes Reula, Adrián Neyra del Rosario, Francisco Acoidan Rodríguez Batista, Miguel Velasco Santos, Juan L Prados-Ojeda, Marina Diaz-Marsà, Manuel Martín-Carrasco, Antonio Cardenas

Article Type

Case Series

Published

This review explores the effectiveness of high doses of lurasidone in managing all schizophrenia symptoms and its role in addressing post-psychotic depression in dual psychosis cases. Additionally, it delves into real-world insights on the clinical application of lurasidone.

Read more

Antibiotic-induced neuropsychiatric toxicity: epidemiology, mechanisms and management strategies – a narrative literature review

Ali A Althubyani, Samantha Canto, Huy Pham, Dana J Holger, Jose Rey

Article Type

Review

Published

This article reviews the epidemiology of antibiotic-induced neuropsychiatric toxicity, explores potential mechanisms of this adverse event, investigates variations in frequency and clinical presentations between different antibiotic classes causing neuropsychiatric toxicity, and discusses management strategies.

Read more

A prospective, observational, multicentre study to evaluate the efficacy of brivaracetam as adjuvant therapy for epilepsy: The Bravo study

Fowzia Siddiqui, Bashir A Soomro, Ehsan U Rehman, Ahsan Numan, Safia Bano, Jawwad Us Salam, Hazim Brohi, Muhammad Zaheer, Faizan Hyder Memon, Muhammad Wahab Qureshi, Junaid Ahmed Sheikh, Abdul Latif Sunejo, Amjad Iqbal, Saira Abbass, Saba Zaidi, Sidrah Nawaz, Kaukab Fatima, Samar Altaf, Neeta Maheshwary, Muhammad Athar Khan, Arjumand Ahmed, Muhammad Iqbal Asif

Article Type

Original Research

Published

The objective of this study was to assess the effectiveness of Brivera when used as an adjunctive therapy for individuals diagnosed with epilepsy.

Read more

Corrigendum: Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system

Guido Mannaioni, Fabio Lugoboni

Article Type

Corrigendum

Published

The authors wish to make the following corrections to their article: Mannaioni G, Lugoboni F. Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system. Drugs Context. 2023;12:2023-2-6. https://doi.org/10.7573/dic.2023-2-6

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.